Companies /Healthcare

Exelixis Inc

NASDAQ: EXEL Biotechnology
$56.78
▼ $0.12 (−0.21%) today
Markets closed · 12:07am ET
24/7 Rating HOLD
12-Month Price Target
$58.69 +2.8% upside

Set by 24/7 Wall St.’s proprietary analysis of professional targets, profit trajectory, sector, risk, and retail attention. How we calculate our price targets →

Current close $57.12
Street consensus $53.69
Ours vs. the Street +9.3%
$50.20Conservative$57.12Current$58.69Our Target$61.55Optimistic
12-Month Projection Historical Optimistic Target Conservative
$42$49$56Sep 2025Sep 2027Today$61.55$58.69$50.20
$42$49$56Sep 2025Sep 2027Today$61.55$58.69$50.20

Analyst Sentiment

19ANALYSTS
Buy737%
Hold1158%
Sell15%
The Bottom Line

Exelixis is fairly valued at current levels. With our price target of $58.69 suggesting modest upside, the stock appears to be trading near fair value. Consider your portfolio allocation and investment timeline before making a decision.

The 24/7 Factor

Base Growth
Conservative growth baseline (reduced to avoid double-counting P/E growth)
1.05×
Sector Momentum
Defensive growth with aging population tailwinds
1.10×
Analyst Consensus
Mixed analyst views
+1.9%
Earnings Growth
Strong earnings acceleration
+2.6%
Volatility Adjustment
Lower volatility stock
+1.2%
Price Position
Upper range of 52-week trading
+0.5%
Social Sentiment
Bearish retail sentiment
−2.2%
Read our full methodology →

5-Year Projection

Long-Term Forecast Optimistic Target Conservative
$56$64$72’26’27’28’29’30’31$74.84$69.36$51.93
$56$64$72’26’27’28’29’30’31$74.84$69.36$51.93

Prediction History

EXEL Price Target History Our Target Stock Price
$55$60$65$70Jul 16Sep 11$59.08$56.12
$55$60$65$70Jul 16Sep 11$59.08$56.12
Date Price Target Stock Price Rating Upside
$59.08 $56.12 BUY +5.3%
$60.90 $59.01 HOLD +3.2%
$68.56 $54.45 BUY +25.9%
$67.85 $54.08 BUY +25.5%
$66.18 $51.24 BUY +29.2%
$68.99 $54.07 BUY +27.6%
$66.56 $53.03 BUY +25.5%
$67.27 $55.42 BUY +21.4%

Social Sentiment

18/100
Sentiment Score
Bearish
Retail Mood
Low
Discussion Activity

Frequently Asked Questions

What is the EXEL stock price prediction for 2030?

Looking ahead to 2030, our model projects EXEL could trade at an average price of $66.72, with a potential range between $50.04 and $83.40. This represents a potential 16.8% return from today’s price. Long-term forecasts depend heavily on company execution, competitive dynamics, and broader market conditions.

Is EXEL a buy, sell, or hold right now?

24/7 Wall St. currently rates EXEL as a HOLD. Near fair value (2.7%) Among Wall Street analysts, 7 rate it Buy, 11 rate it Hold, and 1 rate it Sell.

What is the EXEL stock price target in an optimistic scenario?

Our optimistic scenario for EXEL projects a price of $61.55 over the next 12 months. This represents modest upside of 7.8% from today’s price, suggesting the stock may be fairly valued at current levels even under favorable conditions.

What is the downside risk for EXEL stock?

In our conservative scenario, EXEL could trade as low as $50.20 over the next 12 months, representing a 12.1% decline from current levels. This scenario accounts for potential headwinds including earnings misses, competitive pressures, or broader market weakness.

Projections are estimates based on current data, updated daily. Not investment advice. Learn how we calculate these projections →